Samsung is reportedly working on a revolutionary feature in wearable technology: non-invasive blood glucose monitoring.
This development (thanks, Android Authority), which could debut in the upcoming Galaxy Watch 7, has the potential to impact both healthcare and the smartwatch market significantly. If successful, it would offer a seamless, pain-free method for monitoring glucose levels, addressing a major need for millions of people managing diabetes.
In a news release, Dr. Hon Pak, Samsung’s senior vice president and head of its digital health team, confirmed the company’s ongoing work in this area.
“In particular, blood glucose is a big area of focus for us, and Samsung has been working to develop a sensor algorithm that predicts early signs of diabetes – along with non-invasive blood glucose monitoring technology and continuous glucose monitoring-integrated nutrition coaching,” Dr Pak said.
This statement, coupled with the lack of a similar official announcement from Apple, suggests Samsung may be nearing a breakthrough.
Current methods of glucose monitoring rely on invasive techniques like finger-prick tests or under-the-skin sensors. Samsung’s approach, using optical sensors to analyze glucose levels through the skin, could eliminate the discomfort associated with traditional methods.
During a health forum in San Jose, California, Dr. Pak elaborated on the company’s progress. “What I’m really excited about is our team, as you may have assumed, we are working on a non-invasive optically-based continuous glucose monitor. I can’t tell you the time [of the launch], but I’m very excited about the progress we are making, and this, if we do it right, will be a game-changer,” he said.
The implications of this technology extend beyond individual health management to the broader wearable market. Samsung is in direct competition with Apple, which is also reportedly developing a similar feature for its Apple Watch.
However, Samsung’s decision to discuss its progress publicly suggests it may be ahead in the race. If the technology is accurate, reliable, and successfully integrated into the Galaxy Watch, it could redefine the role of wearables in healthcare.
Despite its potential, challenges remain. Ensuring the accuracy of non-invasive glucose monitoring is critical, particularly for medical applications. Regulatory hurdles in various markets could also delay its rollout.
Nonetheless, Samsung’s track record of incorporating advanced health features, such as ECG and blood pressure monitoring, indicates the company is well-positioned to navigate these challenges.
If Samsung succeeds, this innovation could revolutionize diabetes management, making monitoring more accessible and less invasive. The Galaxy Watch equipped with blood glucose monitoring could set a new standard for wearables, positioning Samsung as a leader in health-focused technology and driving competition within the industry.
